PADOVAN, MARTA

PADOVAN, MARTA  

Università di Padova  

Mostra records
Risultati 1 - 17 di 17 (tempo di esecuzione: 0.045 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Anaplastic Astrocytoma: State of the art and future directions 2020 Caccese M.Padovan M.D'Avella D.Gardiman M. P.Fassan M.Zagonel V. + CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY - -
Clinical management of diffuse low-grade gliomas 2020 Castellano A.Salvalaggio A.Cerretti G.Caccese M.Padovan M.Zagonel V. + CANCERS - -
Corneal side effects induced by EGFR-inhibitor antibody–drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study 2020 Parrozzani, RaffaeleLombardi, GiuseppeMidena, EdoardoLeonardi, FrancescaLondei, DavidePadovan, MartaCaccese, MarioMarchione, GiuliaBini, SilviaZagonel, VittorinaFrizziero, Luisa THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY - -
Impressive response to dabrafenib and trametinib plus silybin in a heavily pretreated IDH wild-type glioblastoma patient with BRAFV600E-mutant and SOX2 amplification 2022 Cerretti, GiuliaCecchin, DiegoDenaro, LucaCaccese, MarioPadovan, MartaZagonel, VittorinaLombardi, Giuseppe ANTI-CANCER DRUGS - -
Indirect functional connectivity does not predict overall survival in glioblastoma 2024 Lorenzo PiniMarta PadovanLuca DenaroMaurizio CorbettaAlessandro Salvalaggio + NEUROBIOLOGY OF DISEASE - -
Knowing when to discontinue Temozolomide therapy in responding aggressive pituitary tumors and carcinomas: a systematic review and Padua (Italy) case series 2023 Padovan M.Cerretti G.Caccese M.Barbot M.Occhi G.Scaroni C.Lombardi G.Ceccato F. + EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM - -
Letter to Editor: Reply to R.T. Casey (Semin Oncol. 2018 Jun;45(3):151-155) 2019 Caccese, MarioFassan, MatteoFassina, AmbrogioPADOVAN, MARTAIacobone, MaurizioScaroni, CarlaZagonel, VittorinaLombardi, GiuseppeCECCATO, FILIPPO + SEMINARS IN ONCOLOGY - -
Metronomic Temozolomide in Heavily Pretreated Patients With Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life Mono-Institutional Study 2023 Cerretti, GPadovan, MCaccese, MDenaro, LGuarneri, VLombardi, G + CLINICAL ONCOLOGY - -
Mismatch-repair protein expression in high-grade gliomas: A large retrospective multicenter study 2020 Caccese M.Fassan M.Cavallin F.Padovan M.Salvalaggio A.Gardiman M. P.Zagonel V. + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
Myeloid Diagnostic and Prognostic Markers of Immune Suppression in the Blood of Glioma Patients 2022 Del Bianco, PaolaPinton, LauraMagri, SaraBasso, DanielaPadovan, MartaVolpin, Francescod’Avella, DomenicoZagonel, VittorinaMandruzzato, Susanna + FRONTIERS IN IMMUNOLOGY - -
Neoplastic Pericardial Effusion: A Monocentric Retrospective Study 2019 MENICHETTI, ALICEDieci M. V.PADOVAN, MARTANAPPO, FLORIANACUMERLATO, ENRICOMiglietta F.Guarneri V.Conte P. + JOURNAL OF PALLIATIVE MEDICINE - -
Ocular Side Effects of EGFR-Inhibitor ABT-414 in Recurrent Glioblastoma: A Long-Term Safety Study 2020 Parrozzani R.Midena E.Londei D.Padovan M.Marchione G.Caccese M.Midena G.Zagonel V.Frizziero L. + FRONTIERS IN ONCOLOGY - -
Patterns of gray and white matter functional networks involvement in glioblastoma patients: indirect mapping from clinical MRI scans 2023 Pini L.Salvalaggio A.Baro V.Padovan M.Anglani M.Facchini S.Denaro L.Lombardi G.Corbetta M. + FRONTIERS IN NEUROLOGY - -
Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study 2020 Lombardi, GiuseppeIndraccolo, StefanoFassan, MatteoMandruzzato, SusannaCaccese, MarioPizzi, MarcoPadovan, MartaMasetto, ElenaGardiman, Marina PaolaDenaro, LucaDei Tos, Angelo PaoloScarpa, AldoZagonel, Vittorina + CANCERS - -
PET/MR in recurrent glioblastoma patients treated with regorafenib: [18F]FET and DWI-ADC for response assessment and survival prediction 2022 Spimpolo A.Berti S.Evangelista L.Causin F.Zorzi G.Caccese M.Padovan M.Zagonel V.Cecchin D. + BRITISH JOURNAL OF RADIOLOGY - -
Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab 2019 Caccese, MarioBarbot, MattiaCeccato, FilippoPadovan, MartaGardiman, Marina PaolaFassan, MatteoDenaro, LucaEmanuelli, EnzoD'Avella, DomenicoScaroni, CarlaZagonel, VittorinaLombardi, Giuseppe ANTI-CANCER DRUGS - -
The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team Evaluation 2022 Tizianel, IreneCaccese, MarioTorresan, FrancescaLombardi, GiuseppeEvangelista, LauraCrimì, FilippoSepulcri, MatteoIacobone, MaurizioPadovan, MartaGaluppini, FrancescaZagonel, VittorinaScaroni, CarlaCeccato, Filippo CANCERS - -